🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Hey... My 2025 prediction came through relatively early... FDA approval for pre-chemotherapy use Lu-177 PSMA-617.

Congratulations to Michael Hofman on winning the prestigious The Royal Australasian College of Physicians Eric Susman Prize for transforming prostate cancer care through theranostics – combining precision imaging with targeted radiation. 🔗 racp.edu.au/news-and-event… #ProstateCancer #Theranostics #EricSusmanPrize

I hope the 2025 Eric Susman Prize inspires many many people to explore a career in nuclear medicine—a fascinating and rapidly evolving internal medicine specialty of the The Royal Australasian College of Physicians, still relatively under the radar. There's never been a more exciting time to be part of this field.

Congrats to A/Prof Shom Goel, has today been awarded the Gottschalk Medal from Australian Academy of Science! His research is reshaping how we treat and understand #breastcancer. A huge honour and well deserved. 👏 🔗 petermac.org/about-us/news-…

#NEWS: Welcome to our new chief medical officer, Phillip Koo, MD! Read the full release: bit.ly/3G0SBOD #NewHire #MedX #MedEd

☢️Ready to specialise in PET/CT or theranostics? Are you enthusiastic and after world-class training in nuclear oncology? In 2026, we have four registrar fellowships positions at Peter Mac Cancer Centre – a place where our normal days are extraordinary. ➡️Eligible candidates can apply now:

Is there a role for PSMA PET/CT in oligometatastic RCC? Check out our JNM PEDESTAL study on PSMA-guided metastasis-directed therapy from Peter Mac Cancer Centre Shankar Siva Michael Hofman 🧍33 pts & 60 metastases 🛜 93% radiotherapy 📖Median follow-up> 4y ✅Local control: 94%

Join in and let’s talk: “Unravelling PSMA Biology” 👉Live, Free & Interactive: link.prostic.org/webinar >750 already registered PSMA Theranostics is booming and it is only the beginning. Let’s unravel PSMA biology together. Join us for a free and an enlightening live session

Unravelling PSMA Biology - 2025 ProsTIC PCF Global Webinar youtu.be/0j1MBJkXjGI?fe… via YouTube 900 registrants from 69 countries !! Incredible speakers.Misha Beltran Louise Emmett Edmond Kwan Martin Pomper, MD PhD Hosts. Declan Murphy Howard Soule Andrea Miyahira

New Frontiers in PSMA Radioligand Therapy Is this the "hottest" session at ASCO #ASCO25 ?? ■ VIOLET: First-in-human trial of Terbium-161 ■ BULLSEYE: Lu-PSMA in oligo-metastatic disease ■ ENZA-p: Biomarkers ProsTIC PCF Science

Come see me Chair the 🔥session at #ASCO25 ASCO with a fantastic line up

Great summary of PSMA PET as an absolute game changer for #prostatecancer staging, patient selection for PLND & theranostics… and we are only at the tip of the iceberg -Renu Eapen #aua25

Incredible prognostic power of PSMA PET from the updated PROMISE large international registry (PPP2): 3 and 5-yr survival data. Superior to NCCN risk score. Data across initial stage, biochemical recurrence, "non-metastatic" castration-resistant, mSPC, MCRPC !! Just out in

Congratulations to our previous Peter Mac Cancer Centre fellow Dr Michal Eifer now back at Sheba Medical Center ... 2025 SNMMI Ones to Watch recognising those with the potential to shape the future of precision medicine across all spectrums of the field.

Last weekend, SNMMI sponsored a summit where nuclear medicine physicians, pharmacists, technologists, and researchers, as well as leaders of peer societies, industry partners, and patients, gathered to further the use of theranostics. Get caught up: snmmi.org/Web/News/Artic…

This week at Peter Mac Cancer Centre in the clinic: Therapy: Tb-161, Ac-225, Lu-177, Ra-223, I-131 Diagnostic: F-18, Ga-68, I-124, Tc-99m, Cr-51 Missing some our friends Zr-89, Cu-64, maybe next week ProsTIC